Julie Hambleton, Director at IGM Biosciences, Inc. (IGMS), sold 15,132 shares at $14.00 ($212K) on 2024-07-25, disclosed to the SEC on 2024-07-29.
Scheduled sale ($212k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SWTX | SELL | 2023-07-21 | $142K | — | Filing → |
| SWTX | SELL | 2023-06-22 | $129K | — | Filing → |
| SWTX | SELL | 2023-03-16 | $35K | — | Filing → |